Skip to main content
Journal cover image

Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.

Publication ,  Journal Article
MacQueen, KM; Eley, NT; Frick, M; Mingote, LR; Chou, A; Seidel, SS; Hannah, S; Hamilton, C
Published in: J Empir Res Hum Res Ethics
July 2016

Good Participatory Practice Guidelines for TB Drug Trials (GPP-TB) were issued in 2012, based on similar guidelines for HIV prevention and reflecting growing acceptance of the importance of community engagement and participatory strategies in clinical research. Though the need for such strategies is clear, evaluation of the benefits and burdens are needed. Working with a diverse group of global TB stakeholders including advocates, scientists, and ethicists, we used a Theory of Change approach to develop an evaluation framework for GPP-TB that includes a clearly defined ethical goal, a set of powerful strategies derived from GPP-TB practices for achieving the goal, and outcomes connecting strategies to goal. The framework is a first step in systematically evaluating participatory research in clinical trials.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Empir Res Hum Res Ethics

DOI

EISSN

1556-2654

Publication Date

July 2016

Volume

11

Issue

3

Start / End Page

203 / 213

Location

United States

Related Subject Headings

  • Tuberculosis
  • Residence Characteristics
  • Outcome Assessment, Health Care
  • Humans
  • Community-Based Participatory Research
  • Biomedical Research
  • 5001 Applied ethics
  • 2201 Applied Ethics
  • 1799 Other Psychology and Cognitive Sciences
  • 1701 Psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
MacQueen, K. M., Eley, N. T., Frick, M., Mingote, L. R., Chou, A., Seidel, S. S., … Hamilton, C. (2016). Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials. J Empir Res Hum Res Ethics, 11(3), 203–213. https://doi.org/10.1177/1556264616657452
MacQueen, Kathleen M., Natalie T. Eley, Mike Frick, Laia Ruiz Mingote, Alicia Chou, Stephanie S. Seidel, Stacey Hannah, and Carol Hamilton. “Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.J Empir Res Hum Res Ethics 11, no. 3 (July 2016): 203–13. https://doi.org/10.1177/1556264616657452.
MacQueen KM, Eley NT, Frick M, Mingote LR, Chou A, Seidel SS, et al. Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials. J Empir Res Hum Res Ethics. 2016 Jul;11(3):203–13.
MacQueen, Kathleen M., et al. “Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.J Empir Res Hum Res Ethics, vol. 11, no. 3, July 2016, pp. 203–13. Pubmed, doi:10.1177/1556264616657452.
MacQueen KM, Eley NT, Frick M, Mingote LR, Chou A, Seidel SS, Hannah S, Hamilton C. Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials. J Empir Res Hum Res Ethics. 2016 Jul;11(3):203–213.
Journal cover image

Published In

J Empir Res Hum Res Ethics

DOI

EISSN

1556-2654

Publication Date

July 2016

Volume

11

Issue

3

Start / End Page

203 / 213

Location

United States

Related Subject Headings

  • Tuberculosis
  • Residence Characteristics
  • Outcome Assessment, Health Care
  • Humans
  • Community-Based Participatory Research
  • Biomedical Research
  • 5001 Applied ethics
  • 2201 Applied Ethics
  • 1799 Other Psychology and Cognitive Sciences
  • 1701 Psychology